Otsuka Hits FDA With New Suit Over Abilify Generics
Otsuka Pharmaceutical Co. Ltd. on Wednesday launched fresh litigation against the U.S. Food and Drug Administration, asking a Maryland federal judge to block regulators from clearing generic competition to its mega-blockbuster...To view the full article, register now.
Already a subscriber? Click here to view full article